Skip to main content
HHS Logo U.S. Department of Health & Human Services NIH logo National Institutes of Health

More Center News

NCATS Support Enables a Promising Therapy to Enter Clinical Trials

A Small Business Innovation Research award has enabled Recursion Pharmaceuticals to advance a potential treatment for a rare disease into clinical testing.

Collaborate with NCATS Scientists on the NIH HEAL InitiativeSM

NCATS welcomes HEAL-related proposals to advance promising compounds and human cell-based models through preclinical development in collaboration with NCATS’ intramural scientists.

NCATS Releases Updated Translational Road Maps

Share your feedback on the new, interactive beta version of the Drug Discovery, Development and Deployment Maps. NCATS has added a more dynamic map interface for enhanced usability.

NCATS-Supported Researchers Find Cell Source Matters for Tissue Chips

Researchers from the Tissue Chip Testing Center at Texas A&M University have evaluated a kidney-on-a-chip’s ability to perform the same functions as real kidneys.

Tiny Organs in Orbit

The NCATS Director discusses how miniature human organs sent into space through the NCATS Tissue Chips in Space initiative will advance exploration of aging and disease.

Rare Diseases Challenge Winners

NCATS selected winners from nearly 50 submissions to a Challenge seeking creative ways to raise awareness about rare diseases and the need for expanded research and patient support.

NCATS-Supported Researchers Find Exercise May Help Protect DNA

CTSA Program-supported researchers found that older caregivers who exercised had longer telomeres. The findings may lead to better health outcomes later in life.

NCATS Internship Helps Promising Student Soar

NCATS mentors students to strengthen their skills across research disciplines and help prepare them for successful scientific careers. Meet summer 2018 intern Bryan Queme.

Potential New Drug Combinations for Childhood Cancers

To help address challenges in treating children with cancer, a team of NCATS researchers is rethinking treatment approaches for several difficult-to-treat childhood cancers.

Director's Corner

Christopher P. Austin, M.D.

February Director's Message

Officially, any disease that affects fewer than 200,000 people in the U.S. is classified as “rare,” and drugs that treat these diseases as “orphans.” Useful as these terms are, they can be misleading and even detrimental to efforts to understand, diagnose and treat people living with these diseases...

Christopher P. Austin, M.D.

In the Spotlight

Clinical and Translational Science Awards Program

Table of Funded Activities 2014 - 2018 (PDF - 121KB)

Small Business Opportunities

riskin sbirNCATS' Small Business Innovation Research and Small Business Technology Transfer programs help small businesses develop and commercialize new translational technologies. Learn More.